Medline prices 60M share secondary offering at $35.50 with concurrent $200M repurchase
FROM THE WIRE · SEEKINGALPHA.COM
Medline (MDLN [https://seekingalpha.com/symbol/MDLN]) announced on Wednesday the pricing of an underwritten secondary offering [https://seekingalpha.com/pr/20731569-medline-inc-announces-pricing-of-secondary-offering-of-class-a-common-stock] of 60M shares of its Class A common…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishA large secondary offering by existing shareholders can weigh on the stock in the short term.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Medline priced 60 million Class A shares at $35.50 per share.
- 02The gross deal value is approximately $2.13 billion.
- 03Shares are sold by affiliates of Blackstone, Carlyle, Hellman & Friedman, GIC and ADIA.
- 04Medline will not receive any proceeds and the offering is expected to close on November 23, 2026.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets